Clinical Trial Update: Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700 [Phase 1]

View source ↗

Summary

Phase 1 PET study assessing dopamine and serotonin receptor occupancy after multiple oral dosing of Lu AF35700 in schizophrenia; study completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Lu AF35700 (Lu AF35700)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2020-05-12